| | | | | 玻璃体腔注射曲安奈德治疗糖尿病性黄斑水肿 | | | 王丽丽;宋虎平;王海燕;朱忠桥;薛晓辉;王睿;黄玲 | | | 目的探讨玻璃体腔注射曲安奈德(intravitrealtriamcinoloneacetonide,IVTA)治疗糖尿病性黄斑水肿(diabeticmacularedema,DME)的疗效。方法回顾性分析25例(28只[)糖尿病性黄斑水肿患者,采用IVTA治疗,剂量为4mg/0.1ml。对比分析治疗前后视力,[压及黄斑区视网膜厚度变化。平均随访6个月。统计学方法采用SPSS13.0软件对各组数据进行处理(秩和检验、配对t检验)。结果治疗后1个月、3个月、6个月,平均视力由术前0.08±0.04分别提高到0.15±0.12、0.16±0.13、0.14±0.12,与治疗前比较差异有统计学意义(P<0.001)。OCT检查黄斑视网膜厚度术前平均为(599.89±135.65)μm,治疗后各时点分别为(249.70±74.69)μm、(243.18±73.19)μm和(245.54±69.33)μm。与治疗前比较有显著性差异(P<0.001)。5只[(17.9%)接受2次IVTA,第一、二次注药时间平均间隔为3个月。9只[(32.1%)[压升高(>21mmHg),局部或全身应用降[压药,[压均能控制正常。结论IVTA是治疗DME的有效方法,能有效改善黄斑水肿和提高视力,降低黄斑区视网膜厚度,但部分黄斑水肿复发,出现一过性[压升高,需进一步观察其长期疗效和安全性。
【作者单位】：西安市第四医院;第四军医大学西京医院眼科;第四军医大学西京医院眼科;西安市第四医院;西安市第四医院;西安市第四医院;西安市第四医院
【关键词】：黄斑水肿,囊样/药物疗法;曲安奈德/治疗应用;糖尿病/并发症
【基金】：陕西省科技攻关项目资金2005K-14G6
【分类号】：R774.5
【DOI】：cnki:ISSN:1006-4443.0.2006-11-024
【正文快照】：
糖尿病性黄斑水肿(diffused diabetic macu-lar edema,DDME)已成为视力损害和致盲的最主要原因之一,目前尚无理想的治疗方法。最近研究报道玻璃体腔注射曲安奈德(intravitreal triam-cinolone acetonide,IVTA)治疗难治性黄斑水肿,取得了一定的疗效[1]。我院采用玻璃体腔注射曲 | | |
| | |  推荐 下载CAJ全文  下载PDF全文 | | | CAJViewer7.0阅读器支持所有CNKI文件格式，AdobeReader仅支持PDF格式 | | | | Intravitreal triamcinolone for the treatment of diabetic macular edema | | | Wang Li-li;Song Hu-ping*;Wang Hai-yan*;Zhu Zhong-qiao;et al.Department of ophthalmology;the fourth hospital of Xi'an.Xi'an;710004;China *Department of ophthalmology;the fourth military medical university.Xi'an;710032;China | | | Objective To investigate the efficacy of intravitreal triamcinolone acetonide (IVTA) for the treatment of diabetic macular edema (DME).Method 28 eyes in 25 patients with DME underwent intravitreal injection of triamcinolone acetonide with 0.1ml(4mg).Best-corrected visual acuity、intraocular pressure and central macular thickness were performed on the patients before and after the injection.The follow-up period was mean 6 months.Statistical analyses were performed by SPPS 13.Results The average visual acuity was 0.08 ± 0.04 before the treatment;while 1、3 and 6 months after the injection,mean visual acuity improved 0.15 ± 0.12、0.16 ± 0.13 and 0.14 ± 0.12,which had statistical significance compared with that before the treatment (P <0.001);The average retinal thickness at macular thickness decreased from (599.89 ± 135.65) μm to (249.70 ± 74.69)μm、(243.18 ± 73.19) μ m and (245.54 ± 69.33)μm.which had statistical significance compared with that before the treatment (P <0.001).5eyes (17.9.%) received two IVTA injections.The mean interval between the first and second IVTA injection was 3 months.Intraocular pressure was raised above 21 mmHg in 9 (32.1%) of 28 eyes,and was controlled to normal level after teratment.Conclusions IVTA is effective in improving vision,reducing macular thickness.Further investigation is warranted to assess the safety of IVTA for the treatment of DME.
【Keyword】：Macular edema,cystoid/drugtherapy;Triamcinolone acetonide/thtapeutie use;Diabe-tes mellitus/complication |
| | | | | | 1 | 喻晓兵,师自安,戴虹,龙力; 曲安奈德玻璃体注射治疗视网膜分支静脉阻塞继发黄斑水肿 [J];中国实用眼科杂志; 2006年10期; 47-49 | | 2 | 王丽丽,宋虎平,王海燕,朱忠桥,薛晓辉,王睿,黄玲; 玻璃体腔注射曲安奈德治疗糖尿病性黄斑水肿 [J];中国实用眼科杂志; 2006年11期; 78-80 | | 3 | 向前,许雪亮,刘双珍,王成业; 5-氟尿嘧啶联合曲安奈德治疗眼睑海绵状血管瘤 [J];眼视光学杂志; 2006年05期; 62-63+71 | | 4 | 关宏程; 醋酸曲安奈德注射液双下鼻甲封闭治疗变应性鼻炎158例分析 [J];中国误诊学杂志; 2007年07期; 153 | | 5 | 丛春霞,李燕; 玻璃体腔注射曲安奈德治疗糖尿病性黄斑水肿的临床观察 [J];中国实用眼科杂志; 2006年06期; 14-17 |
|
|
|